VerityRank

Industry Report

Top 10 Edible Mushrooms Suppliers

October 2026·VerityRank Research Team

Take the label off a punnet of mushrooms and what is left is a building, a compost or substrate recipe and a cold route to a shop; this ranking orders companies by how much of that they own rather than by how loudly they sell.

The distinction is not academic. Global mushroom and fungus sales were put at US$70 billion to US$78 billion for 2025, with compound growth forecast above 8% through 2033. Fresh mushrooms keep for roughly seven to fourteen days and the category's average gross margin has sat between 15% and 25%, so the businesses that hold their ground in a price war tend to own the growing rooms, the substrate yard, the processing hall and the trucks: that footprint is what this index measures first.

The first fork in the industry is a fork in the process, and it runs between a bottle and a bed. East Asian producers grow wood-rotting species (enoki, bunashimeji, king oyster and maitake) in high-density bottles or bags stacked on automated multi-tier racks inside numerically controlled rooms, which lifts output per square metre and removes hands from the line. European and North American producers grow Agaricus bisporus on beds in shelf houses, where the moat sits outside the growing room: upstream in one-, two- and three-phase composting, downstream in refrigeration. Monaghan compounds its own compost and casing rather than buying either in, and Monterey runs its farms with a composting front end attached.

The Chinese entrants ride a capacity curve counted in hundreds of thousands of tonnes a year, and almost all of that volume clears inside one country. Shanghai Snowey Bio-Technology works 18 industrialised bases and pushes 1,500 to 1,600 tonnes a day, above 550,000 tonnes a year and the largest enoki capacity anywhere, yet about 98% of revenue is earned at home. Gansu Zongxing Mushroom Technology runs 16 bases at 1,150 tonnes a day (about 750 tonnes of enoki, 400 of button mushrooms) for more than 400,000 tonnes a year and 99% domestic sales. Jiangsu Hualv Bio-Tech, the newest name here, lifted revenue 25.17% to RMB 1.292 billion and doubled net profit to RMB 110 million from six parks, with 98% of sales in China. The exposure is local: Hualv has no overseas capacity to offset a domestic downturn and leans on new parks reaching design output, Zongxing has seen new lines held up by local planning, and Snowey carries heavy depreciation into a market where regional supply and demand swing hard.

On the other curve, tonnage is an order of magnitude smaller and the money is made at the shelf rather than in the tonne. Monaghan moves more than 3,000 tonnes of fresh mushrooms into European retail weekly, takes 85% or more of its revenue in Europe against 12% in North America, and grows over 200,000 tonnes a year. Monterey earns 90% or more of its revenue in North America on over 100,000 tonnes, and Costa supplies more than three quarters of Australia's fresh mushrooms from about 32,000 tonnes. BioFungi is the smallest entrant here at about 25,000 tonnes, drawing 95% or more of its income from organic retailers and processors in Central and Western Europe. Input costs spare nobody: Monaghan absorbs British and European wages and volatile straw and poultry-litter prices, Hokuto higher Japanese electricity and dearer imported woodchips, and Yukiguni Maitake's core EBITDA is squeezed by substrate and freight costs on about 55,000 tonnes of mostly maitake.

A third model barely touches growing rooms at all, and per tonne it may be the most profitable of the three. Scelta Mushrooms processes more than 45,000 tonnes of button mushrooms a year in four plants with around 350 employees, sells into more than 80 countries and takes 22% of revenue in Asia-Pacific, and it earns that money from umami extracts, a mushroom-derived salt replacer and a bagged product that holds twelve months at ambient temperature, taking refrigeration out of a long-haul order. Two consequences follow: the mushrooms Scelta processes are largely bought in, so it carries an upstream price exposure no grower has, and 350 people serving more than 80 markets must satisfy every labelling and food-safety regime along the route. Monterey is moving the same way by doubling capacity at its extraction business, and Yukiguni Maitake has turned its own maitake into a plant-based meat ingredient.

Compliance has moved out of the marketing department and into the capital budget, where it now works as a condition of staying on the shelf. BioFungi runs three organic plants with HEPA air filtration and has switched to a casing that contains no peat at all, a change that raises unit cost long before it returns anything. Monaghan became the first supplier in the United Kingdom to grow supermarket mushrooms on a fully peat-free system, has moved to recyclable paper and bio-based packaging, and holds a five-year agreement with Sainsbury's inside the retailer's £5 billion programme of long-term farm contracts. Costa, its capital freed by the 2024 buyout, has installed 3D-vision picking arms and solar at its Victorian sites, and Hokuto has automated picking too. Monterey spent 24 months getting its spent mushroom compost certified organic, turning a disposal cost into a saleable input.

Ownership decides how much of this page can be checked, and going private means two different things among these ten. Five of the ten publish audited accounts, and every listing sits in Tokyo or Shenzhen: Snowey (300511) and Hualv (300970) on the Shenzhen ChiNext board, Zongxing (002772) on the Shenzhen main board, and Hokuto (1379) with Yukiguni Maitake (1375) on the Tokyo Stock Exchange Prime Market. Costa is the opposite case: taken private in 2024 by a consortium including Paine Schwartz Partners and Driscoll's, it can fund robots and solar without defending a quarter. Monaghan, Scelta and BioFungi were never public, so their figures come down to company statements and named reporting rather than to a filing. VerityRank checks the current Fortune Global 500 list and none of the ten is a Fortune Global 500 member, so the ceiling of 90 points reserved for those members goes unused.

Set side by side, the ten describe a concentrated industry in which the operational risk is concentrated as well. Monterey's closure of its Royal Oaks farm in California cut 605 jobs and moved that volume to other sites, and a ransomware intrusion in August 2025 exposed employee data and drew consolidated class actions by the following quarter. Read a capacity figure as a statement about how many rooms a company can fill rather than a promise about what they earn.

Cultivated Mushroom Owned-Capacity Index
VerityRank scores edible mushroom suppliers against four weighted dimensions:
• Production Strength and Facility Scale (40%): owned growing rooms, automated climate-controlled bases, compost and substrate capacity and daily and annual tonnage.
• Mushroom Production Concentration (25%): the share of output and turnover that is edible mushrooms, fresh or processed, rather than other crops.
• Global Sales and Financial Performance (20%): consolidated revenue for the latest full year, profitability and the markets served.
• Global Brand Influence and Recognition (15%): retail and foodservice listings, export breadth, breeding and patent standing.
The index caps every score at 90, a ceiling reserved for companies that clear the Fortune Global 500 entry line on their own accounts — US$32.2 billion of revenue for the 2025 edition — and unused on this page. No dimension carries less than (10%) of the total, so no company can ride a single strength to the top.

Data Sources
Principal sources include Hokuto's consolidated results for the year ended 31 March 2025, Snowey's 2025 annual report filed in Shenzhen, Sainsbury's long-term farm agreements, the Monterey Nutra capacity announcement, the organic certification of Monterey's spent compost, litigation coverage of the Monterey data breach, the Monaghan Mushrooms company profile, US mushroom crop value reporting and the Fortune Global 500.

Disclaimer: Figures are taken from audited accounts, exchange filings, company publications and reporting that names its source. VerityRank is paid by no company for inclusion, exclusion or position. Amounts appear in each company's own currency with dollar equivalents approximate, and fiscal years end on different dates; several entrants are privately held, and where such a company publishes nothing this page says so. Estimates are attributed to the publisher that made them, no score is transferred from a parent, an owner or a licensor, and the Fortune Global 500 list is checked directly rather than inferred from revenue. Volume packed or traded for another business rather than produced by the company itself is not credited as its own output, distinct from the operating revenue of the company being scored.

Top 10 Rankings

Edition 2026.11

Hokuto Corporation, which sells under the brand HOKTO, is a Japanese manufacturer of cultivated mushrooms and of the equipment and packaging used to grow them. Founded on 22 July 1964 and headquartered in Nagano City, Nagano Prefecture, it pioneered factory-style mushroom production in Japan: rather than growing outdoors or in sheds, it raises buna-shimeji, maitake, king oyster and white shimeji mushrooms in climate-controlled rooms fed by a bottling line. It is listed on the Tokyo Stock Exchange Prime Market under code 1379. Hokuto Corporation is not a Fortune Global 500 company; forecast revenue of about US$480 million for the 2025/2026 fiscal year is far below the threshold used for the 2025 list.

The company began in 1964 in Nagano Prefecture, a mountainous region with a long foraging tradition for wild mushrooms and little flat farmland, which made controlled indoor cultivation an attractive proposition. Hokuto industrialised the process by standardising substrate, sterilisation and climate control, so output no longer depended on season or weather, and it grew by adding production centres across Japan. Overseas plants in the United States, Taiwan and Malaysia followed, carrying the same cultivation model into markets where the company had no prior retail presence.

The product range is built on four commercial species: buna-shimeji, marketed internationally as the signature HOKTO mushroom, maitake, king oyster and white shimeji. All are sold fresh to supermarkets and food-service customers, mostly in small retail packs, with a smaller processed range. Alongside the food business, the company manufactures agricultural packaging materials and cultivation machinery, which supplies around 12 per cent of revenue and equips both its own plants and other growers. The combination is unusual on this page: Hokuto sells the crop and the industrial means of producing it.

Manufacturing is organised through 19 production centres, including 32 plants in Japan and overseas bases in the United States, Taiwan and Malaysia, with annual capacity of about 75,000 tonnes of buna-shimeji, king oyster and maitake. Cultivation is highly automated: substrate is prepared and inoculated under controlled conditions, rooms run on close environmental control, and harvesting is increasingly supported by machines. Research effort goes into gene breeding and into AI-driven picking robots, the two areas where the company expects further reductions in unit labour cost.

The group operates in 5 countries and regions, led by Japan, where its brand has high retail recognition, with the United States and Southeast Asian markets growing fastest. Forecast revenue for the fiscal year ending in 2026 is JPY 72.5 billion, about US$480 million, of which roughly 88 per cent comes from edible mushrooms and the remainder from agricultural packaging and machinery. About 4,100 people are employed across the network, and the first quarter of the 2025/2026 year was described as solid, with overseas growth the most visible contributor.

The assessment is favourable on technology and disclosure: as a Prime Market listed company, Hokuto reports quarterly and scores well on capital transparency, and its automated model shields it from the labour-cost pressure that has forced farm closures in North America. The near-term risk is domestic cost. Electricity and energy prices in Japan are high, and the woodchips imported for growing substrate have become more expensive, both of which bear directly on a factory model whose largest variable costs are energy and medium. Those pressures are expected to compress profitability in the Japanese business over the short term.

Founded

1964

Workforce

4,100

Facilities

19 production centres; 32 plants in Japan plus US, Taiwan and Malaysia sites

Presence

5 countries and regions (Japan, USA, Malaysia, Taiwan, others)

HQ

Japan

Market cap

$423 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Shanghai Snowey Bio-Technology Co., Ltd. is a Chinese industrialised mushroom producer trading under the brand Snowey. Founded in 1997 and based in the modern agriculture park of Fengxian District, Shanghai, it grows enoki, shimeji, white shimeji, crab-flavour shimeji and king oyster mushrooms under factory conditions rather than in open fields, and sells them fresh across China and into several Asian markets. It is listed on the ChiNext board of the Shenzhen Stock Exchange under code 300511. Shanghai Snowey Bio-Technology is not a Fortune Global 500 company; revenue of about US$360 million in 2025 is a small fraction of the threshold used for the 2025 list.

The company was founded in 1997, when Chinese mushroom production was still dominated by seasonal, labour-intensive methods. Its proposition was to move the crop into climate-controlled factories where temperature, humidity and carbon dioxide can be held constant, so that enoki and shimeji could be produced to a schedule all year and sold in standardised packs. That model was then replicated geographically: bases were added in Jilin, Shandong, Guangdong, Gansu and Sichuan, and later in Thailand, spreading production across different climates and closer to consumption centres.

The fresh range is dominated by enoki and hypsizygus types. Enoki is the volume leader, supported by brown and white shimeji, crab-flavour shimeji and king oyster. All are grown in bottles or bags on prepared substrate, harvested in a single cut and packed for retail, food-service and wholesale channels. A smaller deep-processing business turns part of the crop into prepared products, which normally carries better margins than fresh sales but competes for the same raw material when farm-gate prices are high.

Production is concentrated in 18 modern industrialised bases. Daily capacity exceeds 1,350 tonnes and annual capacity is about 480,000 tonnes, with enoki and shimeji the main contributors. Because every base runs on full factory environmental control, output does not vary with the season and quality is consistent enough for supermarket specification work. Distribution runs through a cold-chain network covering the country's main hubs, combining the company's own logistics assets with third-party carriers, which is the practical way to reach national retail coverage from bases spread across six provinces plus Thailand.

Snowey sells in 3 countries, mainly China, with Thailand and Vietnam serving Southeast Asian demand, and it is among the largest industrialised mushroom producers in the country by daily output. Revenue reached about RMB 2.55 billion in 2025, roughly US$360 million, of which edible mushrooms accounted for about 96 per cent. About 4,500 people work for the group. The scale of the base network is what allows the company to hold volume contracts, but it also means that profitability is driven by industry-wide capacity and pricing rather than by any single product.

Financially, 2025 was a turnaround year. A profit forecast for the period indicated net profit attributable to shareholders of RMB 29 million to RMB 40 million, against a loss of RMB 617 million in the prior year, as surplus capacity in the industry was absorbed and mushroom selling prices stabilised. The recovery is real but thin relative to the asset base: the business carries heavy depreciation on its production facilities, and some regional markets remain exposed to short-term structural swings in supply and demand. A company with 480,000 tonnes of annual capacity has limited room to cut output when prices fall.

Founded

1997

Workforce

4,500

Facilities

18 industrialised production bases (Shanghai, Jilin, Shandong, Guangdong, Gansu, Sichuan, Thailand)

Presence

3 countries (China, Thailand, Vietnam and others)

HQ

China

Market cap

$352 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Monaghan Mushrooms Ireland Unlimited Company is an Irish grower, compost maker and processor of cultivated mushrooms, trading under the brand Monaghan Mushrooms within the wider Monaghan Group. Founded in 1981 at Tyholland in County Monaghan, it was built around button mushrooms and has extended since into brown and portabella types, organic crops, protein powders and extracts, and a bio-technology arm branded MBIO. The group is family controlled and unlisted. Monaghan Mushrooms is not a Fortune Global 500 company; revenue of about US$1.15 billion in 2025 is a fraction of the threshold used to draw up the 2025 list.

The company began as a family mushroom farm in County Monaghan, a border region with an existing growing tradition and easy access to the British market. Growth came from building and acquiring farms rather than franchising: compost production was brought in house, followed by owned growing rooms, packing lines and refrigerated transport, and by the 1990s the business supplied British and continental European retailers directly. Dutch, Belgian and German operations and a Canadian business followed, giving the group year-round supply and a second currency base. The MBIO division is the most recent layer.

The product line is built on the agaricus family: white button mushrooms, brown or cremini types and the larger portabella, sold fresh and pre-packed for retail, alongside organic crops grown to certification. Processing extends the same raw material into sliced and prepared packs, mushroom protein powders and extracts, including selenium-enriched mushrooms and plant-based vitamin D ingredients commercialised through MBIO. The mix matters commercially: fresh mushrooms are priced as a commodity by retail buyers, while extracts and ingredient powders sell into health and food-manufacturing markets where dried mushroom solids carry far higher value per kilo.

Production is vertically integrated to an unusual degree. The group operates 12 large vertically integrated farms and compost substrate plants, and controls the sequence from substrate manufacture and liquid inoculation through climate-controlled growing, harvesting, packing and cold-chain transport. Compost and casing are made in house, removing a bought-in cost and a quality variable most growers cannot avoid. Annual output exceeds 200,000 tonnes, and the growing platform spans six countries: Ireland, the United Kingdom, the Netherlands, Canada, Belgium and Germany.

Selling runs through retail and food-service supply rather than consumer advertising, so the Monaghan name is better known to category buyers than to shoppers. The geographic spread is weighted towards markets where fresh mushroom consumption is mature, chiefly the United Kingdom, Ireland and continental Europe, with Canadian capacity serving North American demand. On sustainability, the group moved to 100 per cent recyclable paper and bio-based packaging across its European operations in 2025 and 2026, and biomass recovery has cut natural gas use in the growing rooms.

The assessment is positive but qualified. Vertical integration gives Monaghan cost and quality control smaller competitors cannot match, and MBIO offers an option on higher-margin ingredient demand. The near-term outlook, however, is dominated by cost: labour costs in the United Kingdom and Europe have risen, and compost inputs such as straw and poultry litter have been volatile in price, squeezing a business whose fresh product is bought by retailers on annual terms. At this scale the group has less room than a listed rival to absorb those swings.

Unlisted

Founded

1981

Workforce

3,500

Facilities

12 vertically integrated farms and compost substrate plants

Presence

6 countries (Ireland, UK, Netherlands, Canada, Belgium, Germany)

HQ

Ireland

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers
4Monterey Mushroom Holdings, LLC

Monterey Mushroom Holdings, LLC, which trades as Monterey Mushrooms, is a United States grower, packer and distributor of fresh cultivated mushrooms. Founded in 1971 and based in Watsonville in Santa Cruz County, California, it grows white, brown and portabella types, markets organic and vitamin D-enhanced lines, and converts spent growing substrate into certified organic compost. The company is privately held and unlisted. Monterey Mushrooms is not a Fortune Global 500 company; revenue of about US$650 million in 2025 is a small fraction of the threshold used for the 2025 list, and it is not a subsidiary of one either.

The business dates from 1971 and was built in the California coastal belt around Watsonville and Morgan Hill, where cool marine air and proximity to the produce trade of the Pajaro and Salinas valleys favoured year-round mushroom growing. From that base it expanded by adding farms and distribution points rather than by acquiring brands, and it is now one of the largest fresh mushroom growers in North America. Ownership is private and the company publishes no audited accounts, so its outside visibility comes mainly from trade coverage and from the financing it arranges.

The fresh line-up covers the three commercial agaricus types, white mushrooms, brown or Baby Bella and the larger portabella, together with organic crops and mushrooms enriched with vitamin D using a patented ultraviolet treatment. That treatment is the clearest product differentiator the company holds: it raises vitamin D content in the harvested crop without additives, and it lets retail packs carry a nutrient claim that commodity mushrooms cannot. Composting is the third activity, turning spent substrate from the farms into organic soil amendments sold to Californian growers.

Production runs through 7 large smart production sites and distribution centres, spread across California, Texas, Pennsylvania and Illinois, with further capacity in Mexico. The layout places growing close to major metropolitan markets and shortens the refrigerated haul into retail distribution centres, which matters because fresh mushrooms are perishable and heavy relative to their value. Annual capacity is about 130,000 tonnes, and the group operates in 2 countries, the United States and Mexico, with roughly 2,000 employees after the reorganisation completed in 2025.

Sales go overwhelmingly into the fresh mushroom category, which represents about 98 per cent of revenue, and reach mainstream North American supermarket chains and food-service distributors, with the balance coming from compost and related products. Because mushrooms are sold as a fresh commodity, retail programmes are won on price, supply reliability and pack format rather than on brand preference. That makes the vitamin D lines and organic certification the main routes to a premium, and the compost business a way to recover value from material that would otherwise be a disposal cost.

The assessment has to weigh a strong franchise against a hard restructuring. In late 2025 and early 2026 the company arranged a US$22 million senior secured credit facility with Gibraltar Business Capital to automate and modernise its farms, and it released a certified organic spent mushroom compost to California farmers, both of which point to a business investing to defend its position. But it also closed its 275-acre Royal Oaks farm in California and laid off 605 workers, shifting that volume to Morgan Hill and to farms in other states, a decision attributed to ageing facilities and to high regulatory and labour costs in the state.

Unlisted

Founded

1971

Workforce

2,000

Facilities

7 production sites and distribution centres (California, Texas, Pennsylvania, Illinois, Mexico)

Presence

2 countries (United States, Mexico)

HQ

United States

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Yukiguni Maitake Co., Ltd. is a Japanese cultivator and processor of speciality mushrooms that sells under the consumer brand Yukiguni Maitake. Its head office is in Minamiuonuma, Niigata Prefecture, the snow-country district that gave the company its name and where most of its growing capacity still sits. The business was founded in 1983 and is listed on the Prime Market of the Tokyo Stock Exchange under the code 1375, one of four exchange-listed growers among the ten companies on this page. Yukiguni Maitake Co., Ltd. is not a Fortune Global 500 company: revenue of about JPY 48.2 billion, or roughly US$320 million, in the 2025/2026 financial year is about one per cent of the approximately US$32.2 billion threshold applied for the 2025 list, and no shareholder of the company is a member of it.

The company's identity rests on a single species. Maitake is harder to fruit indoors at industrial scale than button mushrooms or enoki, and sterile artificial cultivation technology for the species is what turned Yukiguni Maitake from a regional grower into the leading supplier of maitake in Japan. That technical lead is also why the species still commands a premium at retail, and why the company's margins have depended more on mix than on volume. King oyster and brown beech mushrooms and processed health-food products widen the base, but the premium still rests on maitake.

Revenue for the 2025/2026 financial year is JPY 48.2 billion, approximately US$320 million, of which mushrooms account for about 94% and processed food lines for the remainder. Output runs at around 55,000 tonnes a year from eleven modern fruiting and processing plants, most of them in and around Niigata Prefecture. About 1,150 people are employed across the group, small against the tonnage, reflecting heavily automated growing rooms. The company reports operations in three countries and regions, Japan dominant among them, and sells roughly 45% of its non-maitake mushroom lines overseas.

Founded in 1983 in a region whose cold winters and clean water suit controlled cultivation, the company grew from a local producer into a national supplier and then into a listed business. It has kept cultivation and processing close together in Niigata rather than dispersing them across contract farms, which is expensive to build and slow to copy, and that is why the position has proved defensible. The same choice leaves the group carrying Japanese energy, materials and labour costs in full, with no low-cost offshore base to offset them.

Trading in the 2025/2026 year has been about price rather than volume. Shipping prices for the company's mushrooms stabilised and then began to recover in the second quarter, and management has worked the retail side of the business by promoting small, high-freshness packs and a wider range of cooking suggestions, including promotional partnerships with social media influencers. Those measures raise the value of a fixed harvest rather than requiring a larger one. Investment continues in automation, sterile cultivation research and processed health-food lines built on maitake extracts.

Cost inflation is the immediate problem. Sawdust and nutrient substrates are largely bought in, freight charges have risen, and together they have pressed core EBITDA year on year; the company has responded with manufacturing cost reduction and flexible control of production volumes rather than with price increases that a price-sensitive domestic market may not accept. The longer-term exposure is the premium itself: if maitake loses its speciality status, or if larger commodity growers replicate sterile cultivation and add capacity, the pricing advantage that supports the whole position narrows.

Founded

1983

Workforce

1,150

Facilities

11 fruiting and processing plants, mainly in Niigata Prefecture

Presence

3 countries and regions; Japan dominant

HQ

Japan

Market cap

$287 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Gansu Zongxing Mushroom Technology Co., Ltd. is a Chinese industrialised grower of enoki and button mushrooms, trading under the brand Zongxing Mushroom. Founded in 2005 and headquartered in the national agricultural science and technology park in Tianshui, Gansu Province, it grows both crops in climate-controlled rooms, formulates its own substrate and runs its own spawn breeding, and sells fresh mushrooms across China. It is listed on the main board of the Shenzhen Stock Exchange under code 002772. Gansu Zongxing Mushroom Technology is not a Fortune Global 500 company; revenue of about US$295 million in 2025 is far below the threshold used for the 2025 list.

The company was established in 2005 in Gansu, a north-western province where cool conditions and cheap land made industrialised cultivation viable, and it began with enoki mushrooms grown in bottles in insulated rooms. The second crop, the agaricus button mushroom, was added later and is produced on a composting rather than a bottle system, so the company now runs two different technologies side by side. Expansion since then has been geographic: bases were built in Shaanxi, Shandong, Jiangsu, Sichuan and Anhui, and a joint venture project took the business outside China for the first time, to Poland.

The fresh product range is narrow and deliberate. Enoki is the larger line, sold in consumer packs and in bulk for food service and hotpot-style catering, and button mushrooms form the second pillar, supplying the retail and processing markets that Western-style mushrooms serve in China. Spawn and strain breeding sit upstream and are treated as a business in their own right. The company also formulates its own growing substrate from liquid spawn fermentation onwards, which keeps the two most failure-prone steps of industrialised cultivation, the culture and the medium, inside the company.

Production runs through 16 modern production bases. Annual capacity exceeds 360,000 tonnes, with button mushrooms at roughly 300 tonnes a day and enoki above 700 tonnes a day. Rooms are intelligently controlled and the process from substrate mixing to harvest is scheduled rather than seasonal, so output is stable through the year and quality is repeatable enough for supermarket programmes. Because the bases are distributed across six provinces, freight distances to the main consumption regions are shorter than they would be from a single mega-site, but each location carries its own fixed overhead.

Revenue for 2025 was RMB 2.098 billion, about US$295 million, up 8.43 per cent year on year, with net profit attributable to shareholders of RMB 335 million. Edible mushrooms account for about 99 per cent of sales, the purest category focus on this page. The company operates in 2 countries, China and the Poland joint venture project, and employed about 3,800 people. Trading held up into 2026, with first-half revenue of RMB 1.085 billion, suggesting that the cost and utilisation advantages behind the 2025 result persisted into the following period.

The financial performance is the strongest of the Chinese producers here: a company that earned RMB 335 million in 2025 while a larger domestic rival was recovering from a loss of RMB 617 million, and it did so on roughly a third of that rival's revenue. The risks are execution and price. Some new production lines have had their construction schedules adjusted slightly by local planning requirements, so the timing of capacity additions is not entirely within the company's control, and both of its crops are commodities whose prices move with national supply. A grower with 99 per cent of revenue in mushrooms has no other business to absorb a price trough.

Founded

2005

Workforce

3,800

Facilities

16 production bases (Gansu, Shaanxi, Shandong, Jiangsu, Sichuan, Anhui)

Presence

2 countries (China; Poland joint venture project)

HQ

China

Market cap

$393 M

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers

Jiangsu Hualv Bio-Tech Co., Ltd. is a Chinese industrialised mushroom grower listed on the ChiNext board of the Shenzhen Stock Exchange under code 300970. Founded in 2010, it is based in the Siyang Economic Development Zone in Suqian, Jiangsu Province, in one of the densest clusters of factory-scale mushroom production in the country. Its crop is grown indoors on fully automated computer-controlled lines rather than on open farmland: enoki mushrooms, beech mushrooms sold as white shimeji and as crab-flavour shimeji, and maitake. Jiangsu Hualv Bio-Tech is not a Fortune Global 500 company, and no company on that list owns it; revenue of RMB 1.292 billion in 2025 is about US$181 million, well under one per cent of the roughly US$32.2 billion threshold used for the 2025 list.

The company is young by the standards of this list. It appeared in 2010, at a moment when Chinese demand for enoki and beech mushrooms was moving from seasonal outdoor growing to year-round cultivation in climate-controlled rooms, and it has expanded by repeating a single plant design across provinces rather than by buying existing growers. Siyang in Jiangsu remains the base, and the group has since added Nanchuan in Chongqing, Wangdu in Hebei and sites in Guangxi, each placed close to the water, labour and agricultural by-products that industrialised cultivation consumes. Its ChiNext listing funded that build-out.

The range is narrow by design. Enoki is the volume line and the most exposed to the domestic price cycle, because Chinese enoki supply has grown faster than consumption in several recent years. Beech mushrooms, in white and brown forms including the crab-flavour type, carry a higher unit value and are sold both in consumer packs and in bulk to food service. Maitake is the smallest line and the closest to the premium end of the home market. Substrate is mixed in-house from agricultural by-products, filled into bottles, inoculated with spawn the group maintains itself and fruited in multi-tier rooms under tightly controlled temperature, humidity, light and carbon dioxide.

That method is repeated across six large intelligent production parks. Daily capacity is about 850 tonnes, or about 310,000 tonnes a year, and the group employs about 2,800 people. Six parks in a single country is a different shape from the multinational footprints of the Japanese and European growers on this list: each site is sized to its own region, and the two newest, in Chongqing and Hebei, were the main reason the 2025 results moved as they did.

Revenue in 2025 reached RMB 1.292 billion, an increase of 25.17% on the previous year, and net profit attributable to shareholders of the listed company doubled to RMB 110 million. China accounted for 98% of revenue, about RMB 1.27 billion of the total, so the improvement came from the ramp-up of new parks rather than from price. Brand heat in this study's assessment is 83 out of 100, reflecting a leading position in eastern and south-western China and a much weaker presence abroad.

The risk sits in the same numbers. With 98% of revenue earned at home and no overseas production to offset a domestic downturn, Hualv holds no hedge against the enoki and beech price swings that have punished Chinese growers whenever industry capacity arrives in a block. Its own expansion sharpens the exposure: the new parks carry fresh depreciation, so if wholesale mushroom prices fall while utilisation is still climbing, fixed cost per tonne rises exactly as the selling price falls. The company is growing into the price cycle rather than out of it.

Founded

2010

Workforce

2,800

Facilities

6 intelligent mushroom production parks: Siyang, Nanchuan, Wangdu, Guangxi and others

Presence

1 country: China; 98% of revenue domestic

HQ

China

Market cap

$244 M

Agricultural ProductsAgricultural Products SuppliersEdible Mushrooms Suppliers

Costa Group Holdings Pty Ltd is an Australian horticultural grower, packer and marketer of fresh produce that trades under the brand Costa, with consumer labels including MushBoom, Perino and Lovacado. Its business support centre is at Level 5, 818 Bourke Street, Docklands, VIC 3008, Australia; the long-standing registered and principal address up to August 2023 was 275 Robinsons Road, Ravenhall, VIC 3023. Costa Group is not a Fortune Global 500 company. It has been privately held since February 2024 and its last public full-year revenue, A$1,458.55 million for FY2023, is far below Fortune Global 500 scale; no consortium member's size is Costa's own size.

The business traces to a family produce operation in the late 1800s. Company history dates its origins to 1895, when Francesco Costa arrived in Australia from Salina, Italy, and the February 2024 take-private announcement describes a company started by the Costa family in Geelong, Victoria with a more than 120-year history. The founding year of 1888 that appears in third-party reference material such as Wikipedia has no company source. The listed entity, ACN 151 363 129, was registered on 29 June 2011, floated on the ASX in July 2015 and was renamed Costa Group Holdings Pty Ltd on 3 June 2024 after the take-private.

FY2023, the year ended 31 December 2023, produced revenue of A$1,458.55 million, sales of A$1,420.73 million and a net loss of A$24.32 million, against FY2022 revenue of A$1,357.56 million and net income of A$33.63 million. The last half-year disclosure, the 26 weeks ended 2 July 2023, reported revenue of A$770.7 million, up 8.7%, EBITDA-S of A$150.2 million, NPAT-S of A$37.8 million and net debt of A$350.1 million at 2.31x leverage. No FY2024 or FY2025 results exist publicly: Costa was taken private in February 2024 and no longer files financial statements.

Production spans four countries. In Australia the group runs mushroom farms at Monarto in South Australia, Mernda in Victoria and Casuarina in Western Australia; glasshouses at Guyra in New South Wales; citrus farms and packhouses including Kangara at Murtho and Yandilla at Renmark; berry farms in four states with a packhouse and distribution centre at East Devonport; a banana farm at Walkamin; and avocado farms at Comboyne, Fishermans Reach and four Queensland sites. Berry International operates nine growing sites in Yunnan, China, farms at Larache and six further Moroccan locations, and a new operation at Paksong in Laos. Total cropping area is 8,532 hectares, of which 2,565 hectares, or 30%, is protected, and the 2025 workforce was 11,156 FTE direct hires.

Ownership is a consortium structure. Costa was acquired by Chilli Buyer Pty Ltd, a bidco for a consortium led by Paine Schwartz Partners with Driscoll's, Inc. and British Columbia Investment Management Corporation, at A$3.20 cash per share, an equity value of about A$1,496 million and an enterprise value of about A$2,459 million; Paine Schwartz and Driscoll's affiliates held about 19.62% of the shares before the scheme. Driscoll's is a minority co-investor and long-standing berry joint-venture partner, not the acquirer. On category claims: Australia's largest citrus grower and Australia's leading mushroom grower are company statements, but for berries its website says only that it is one of Australia's leading berry producers. Stone fruit is not a disclosed core category, and no country count or facility count is published.

Unlisted

Founded

1895

Workforce

11,156

Facilities

Mushroom farms Monarto SA, Mernda VIC, Casuarina WA; glasshouse Guyra NSW; citrus Murtho & Renmark SA; berry packhouse TAS; China (Yunnan) nine sites; 8,532 ha cropping

Presence

Australia plus China (Yunnan), Morocco, Laos; varieties licensed in the Americas, Africa

HQ

Australia

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products BrandsAgricultural Products Suppliers
9Scelta Mushrooms B.V.

Scelta Mushrooms B.V. is a Dutch processor of cultivated mushrooms, based at Heymansstraat 35 in Venlo, Limburg, and founded in 1993. The company is privately held and publishes no audited accounts, so its revenue is an estimate: about US$180 million in 2025. Its business is built on the button mushroom, but not on selling it fresh: Scelta cooks, freezes, dries and extracts the crop into flavourings and ingredients for food manufacturers, caterers and retailers. Scelta Mushrooms B.V. is not a Fortune Global 500 company and is not owned by one; revenue of about US$180 million is a small fraction of the roughly US$32.2 billion threshold applied for the 2025 list.

The company dates from 1993 and has stayed in the same corner of the Netherlands since. Venlo remains the head office, and capacity was added at Kruiningen in Zeeland and at Belfeld rather than abroad. Privately held, unlisted and without public bonds, Scelta reports nothing about its margins, debt or ownership, so it can be judged only on what it owns and makes: its plants, its research centre and its substrate technology.

The range divides into three parts. Processed button mushrooms are the volume base: sliced, diced, grilled and cooked formats sold frozen or chilled to food manufacturers, caterers and retail chains. Flavour is the margin business: mushroom extracts and concentrates sold as natural umami, used to give savoury depth to products containing no meat, now extended into a mushroom-derived salt replacer for sodium reduction. Scelta Essential is the third line: preservative-free packed mushrooms with a twelve-month shelf life. The three share one starting point: raw button mushrooms are bought from outside growers, and the value the company adds lies in how they are handled, stabilised and concentrated afterwards.

Processing runs through four high-tech plants and automated climate-controlled halls in the Netherlands: Venlo, Kruiningen and Belfeld. Combined annual capacity exceeds 45,000 tonnes of mushrooms, a different measure from the growing capacity recorded elsewhere on this page: throughput depends on how much crop it can buy and handle, not on how many fruiting rooms it owns. About 350 people work across the group, a small workforce for a business of this scale, reflecting how continuous the process is: blanching, freezing, drying and extraction are machinery rather than manual work.

The group sells into more than 80 countries. Asia-Pacific, including high-end catering and prepared-meal makers in China, accounts for 22% of revenue, a larger share than the distance from Venlo would suggest; frozen and shelf-stable formats make that trade possible. Scelta Essential was launched in 2025 with no preservatives and a twelve-month shelf life, aimed at the cost of moving mushrooms around the world: longer shelf life means ordinary freight instead of an unbroken cold chain and opens retail formats that fresh mushrooms cannot reach. The mushroom-derived salt replacer follows the same logic, converting a commodity crop into a functional ingredient sold by dose rather than by weight.

Scelta does not grow what it processes. Its raw button mushrooms come from external growers, so its margins move with the fresh mushroom price and the reliability of supply, and a processor on annual contracts cannot always pass a raw-material spike through. Serving more than 80 countries with about 350 employees also concentrates a great deal of food-safety, labelling and customs obligation into a small organisation, where failure is expensive and public. Flavour extraction is a crowded field too, with large ingredient groups chasing the same customers, so the premium earned on umami and salt replacement must be defended continuously.

Unlisted

Founded

1993

Workforce

350

Facilities

4 high-tech processing plants and climate-controlled halls (Venlo, Kruiningen, Belfeld)

Presence

Exports to 80+ countries; 22% of revenue in Asia-Pacific

HQ

Netherlands

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products SuppliersEdible Mushrooms Suppliers
10BioFungi GmbH

BioFungi GmbH is a German organic mushroom grower based at Eugen-Gerstenmaier-Strasse 4 in Krefeld, North Rhine-Westphalia, and founded in 2000. It is privately held and publishes no audited accounts, so its revenue is an estimate: about US$130 million for 2025. The company grows certified organic button, shiitake and oyster mushrooms under the EU Organic standard and also produces organic fungal substrate, working from its own farms rather than through contract growers. BioFungi GmbH is not a Fortune Global 500 company and is not owned by one; revenue of about US$130 million is far below the roughly US$32.2 billion threshold applied for the 2025 list.

The company was founded in 2000, when organic food was moving out of specialist shops and into mainstream German retail, and it has stayed in that niche ever since. Certification is its licence to operate: EU Organic rules govern the substrate, inputs, pest control and traceability of every batch, and the premium organic mushrooms command in Germany, Austria and Switzerland depends on holding it without interruption. Privately held and unlisted, BioFungi publishes nothing about its ownership, margins or debt, which leaves its plants and output as the only measurable facts.

The range is built on three species. Button mushrooms, the Agaricus types that dominate European consumption, are the volume crop, supplied fresh to retail. Shiitake and oyster mushrooms extend the offer onto the speciality shelf, where organic certification is comparatively rare and margins are wider. Behind the crop sits a second business, organic fungal substrate, produced by the group and sold on, which draws on the same raw materials as its own cultivation. Running both sides of that boundary gives BioFungi more control over its growing medium than growers who buy compost on the open market have.

Production runs through three organic mushroom plants in Germany, each fitted with HEPA air filtration. That is unusual in this industry: filtered air defends against spores and contaminants in a crop grown without synthetic pesticides. Annual organic capacity is about 25,000 tonnes and the group employs about 400 people. Operations extend across three countries, Germany, Austria and Switzerland, a compact footprint covering the three largest German-speaking organic markets in Europe.

More than 95% of revenue comes from organic supermarkets and food processors in Central and Western Europe, so the customer base is narrow in channel terms even though it is international. The most significant development of 2025 was technical: BioFungi moved to 100% peat-free organic casing soil, removing peat from a process that has depended on it for decades. Peat extraction is being restricted across Europe on carbon and habitat grounds, and a grower that has already made the change is positioned ahead of rules that will press on competitors still buying peat-based casing.

The risk is scale. At about 25,000 tonnes and roughly 400 employees, BioFungi is the smallest producer on this list, which limits its bargaining power over packaging, energy, logistics and substrate inputs and leaves little cushion if a season goes wrong. Its customers are concentrated as well: with 95% or more of revenue coming from organic retail and food processors in Central and Western Europe, the growth of retailer own-brand organic mushrooms and the discounting that comes with it fall directly on its margins. Certification and the peat-free conversion are a lead, but they also raise unit costs, and against non-organic producers selling at conventional prices that gap is a permanent disadvantage rather than a temporary one.

Unlisted

Founded

2000

Workforce

400

Facilities

3 organic mushroom plants with HEPA air filtration (Germany)

Presence

3 countries: Germany, Austria and Switzerland

HQ

Germany

Type

Brand

Market

Unlisted

Agricultural ProductsAgricultural Products SuppliersEdible Mushrooms Suppliers

Frequently Asked Questions

05
Why Do East Asian Mushroom Rooms Run On Bottles And Bags While European Ones Run On Beds, And What Does Each Model Actually Own?

The two dominant production systems grow different species with different biology, and they force the operator to own different things, which is why a mushroom supplier's capacity has to be read against the system it uses rather than in the abstract. A mushroom is a fungus rather than a plant, and the two commercial approaches on this page barely resemble each other. In East Asia the volume crops are wood-rotting species: enoki, bunashimeji, king oyster and maitake. In Europe and North America the volume crop is Agaricus bisporus, the button mushroom, which grows on compost. That single biological difference decides where the cost sits and what a company has to build.

Bottle and bag rooms put the engineering inside the building. Substrate is mixed to a recipe from sawdust, bran and corn cobs, sterilised, filled into heat-resistant bottles or into bags, and inoculated with liquid spawn. The containers are stacked on multi-tier racks inside climate-controlled rooms where temperature, humidity, light and carbon dioxide are set by control systems rather than by weather, and the crop is harvested on a fixed cycle. This is why capacity in the East Asian model is quoted as a daily figure: Shanghai Snowey Bio-Technology runs 18 industrialised bases at 1,500 to 1,600 tonnes a day, above 550,000 tonnes a year, while Gansu Zongxing Mushroom Technology runs 16 bases at 1,150 tonnes a day, split between about 750 tonnes of enoki and 400 tonnes of button mushrooms, and Jiangsu Hualv Bio-Tech runs six parks at roughly 850 tonnes a day. Hokuto grows more than 70,000 tonnes a year on the same principle. The exposure attached to it is energy and bought-in inputs: Hokuto has absorbed higher Japanese electricity bills and dearer imported woodchips and corn cobs.

Shelf houses move the difficulty upstream into compost and downstream into the cold chain. Agaricus bisporus grows on composted straw and poultry litter rather than on sterilised sawdust, and that material has to be prepared in one, two or three phases, pasteurised and laid into beds before a single mushroom fruits. The competitive position therefore sits outside the growing room, in the recipe, the pasteurisation regime and the speed of the refrigerated route. Monaghan compounds its own compost and casing rather than buying either in and moves more than 3,000 tonnes of fresh mushrooms into European retail every week from six countries, and Monterey runs its farms with a composting front end attached. A supplier that buys compost is buying the part of the process that decides yield.

What each model owns is different, and so is what each can lose. A bottle or bag operation owns rooms, a spawn laboratory, a substrate mixer and a packing line, and it can change species by rewriting the recipe. A shelf house owns compost yards, casing, bed structures and refrigerated vehicles, and it is far more committed to the one species it grows. Neither owns the shelf that sells the crop, which is why route to market matters as much as tonnage. Costa supplies more than three quarters of Australia's fresh mushrooms from about 32,000 tonnes, a figure that describes the size of its market as much as its engineering, and BioFungi grows about 25,000 tonnes using the Western model and sells almost all of it through organic retail in Central and Western Europe. The two systems become comparable only once the species, the market and the unit of measurement are held constant.

Why Does Chinese Capacity Reach Six Figures In Tonnes While European Output Stays A Fraction Of It, And Which Curve Carries The Margin?

Chinese capacity is counted in tonnes per day for a market that sits inside one border, while European and North American capacity is counted in tonnes per year for channels that pay more per kilo, and both curves are accurate descriptions of different businesses. The distance between them is not a gap in engineering competence. It is a difference in what each group optimises: volume per room against margin per pack, and domestic coverage against certification and export reach.

China measures output in tonnes per day and sells it at home. Shanghai Snowey Bio-Technology works 18 industrialised bases at 1,500 to 1,600 tonnes a day, above 550,000 tonnes a year and the largest enoki capacity anywhere, yet about 98% of its revenue is earned at home. Gansu Zongxing Mushroom Technology runs 16 bases at 1,150 tonnes a day for more than 400,000 tonnes a year and 99% domestic sales. Jiangsu Hualv Bio-Tech runs six parks at roughly 850 tonnes a day and more than 310,000 tonnes a year, with 98% of sales in China. The engineering behind those numbers is real, but the demand behind them is a single national market, and that is where the risk sits: Snowey carries heavy depreciation and reads a market in which regional supply and demand swing hard, Zongxing has seen schedules for some new lines held up by local planning decisions, and Hualv has no overseas capacity to offset a domestic downturn and depends on its newest parks reaching design output.

Europe and North America sell fewer tonnes into better-paying channels. Monaghan grows more than 200,000 tonnes a year, takes 85% or more of its revenue in Europe and 12% in North America, and moves more than 3,000 tonnes of fresh mushrooms into European retail every week. Monterey earns 90% or more of its revenue in North America on over 100,000 tonnes. Costa supplies more than three quarters of Australia's fresh mushrooms from about 32,000 tonnes. BioFungi is the smallest entrant here at about 25,000 tonnes and draws 95% or more of its income from organic retailers and processors in Central and Western Europe, where certification is the pricing mechanism. Yukiguni Maitake sells about 55,000 tonnes of mostly maitake, holds more than 60% of the Japanese maitake market and takes 92% of its sales at home, which is the premium-species version of the same argument.

The margin in fresh mushrooms is narrow, which is why tonnage alone settles nothing. A fresh mushroom has roughly seven to fourteen days of usable life and the category's average gross margin has sat between 15% and 25%, so a supplier that loses control of either energy or freight can lose the year. Hokuto has taken higher Japanese electricity bills and dearer imported woodchips and corn cobs, Monaghan absorbs British and European wage costs alongside volatile straw and poultry-litter prices, and Yukiguni Maitake has seen core EBITDA squeezed by substrate and freight costs. Scale protects against none of that on its own.

Capacity becomes comparable only after four things are fixed. The first is the unit: 550,000 tonnes a year and 1,500 tonnes a day describe the same business in two notations, and mixing them distorts any ranking. The second is the perimeter, since Costa's mushroom operation is a division inside a larger horticultural group rather than a standalone company. The third is the boundary between harvested and handled volume, because Scelta's 45,000 tonnes is intake at a processing plant rather than a crop lifted from a room. The fourth is currency and fiscal year, since yen, renminbi and euro accounts close on different dates and the dollar equivalents on this page are approximations.

What Is A Processor Doing On A Suppliers Ranking, And How Does Scelta Earn Its Margin From Mushrooms It Does Not Grow?

Owned capacity in this industry is not only growing rooms, and Scelta Mushrooms belongs on this page because it owns the plants, the recipes and the research laboratory that turn bought-in button mushrooms into ingredients sold in more than 80 countries. The index gives production strength and facility scale a 40% weight and production concentration 25%, and a processor qualifies on both counts: its assets are factories and its turnover is entirely mushroom. Reading it as an anomaly misses where a growing share of the category's margin is assembled.

The ownership test asks what is on the balance sheet rather than what is in the field. Scelta runs four specialised plants with automated climate-controlled halls at Venlo, Kruiningen and Belfeld in the Netherlands, a research centre of its own and substrate technology it controls, and it processes more than 45,000 tonnes of button mushrooms a year with about 350 employees. It is privately held, so its revenue of about US$180 million is an estimate rather than an audited figure. Set that asset base beside a grower's and the difference is clear: no cropping land, no compost yard and no fleet of growing rooms, but cooking, slicing, blanching, freezing, drying and extraction capacity, which is where its capital sits.

Shelf life and formulation are the moat, not yield per square metre. Fresh mushrooms last about seven to fourteen days and the category's average gross margin has sat between 15% and 25%. Scelta replaces that constraint with a preservative-free retail pack that keeps for twelve months at ambient temperature, which takes refrigeration out of a long-haul order, and with umami extracts and a mushroom-derived salt replacer sold to food manufacturers rather than to shoppers. The margin is earned on formulation, and the same move is visible elsewhere: Monterey has doubled capacity at its extraction business to meet demand for functional mushroom ingredients, and Yukiguni Maitake has turned its own maitake into a plant-based meat ingredient.

The risk is upstream and it is structural rather than temporary. The boundary of what Scelta owns sits at the intake door, and the mushrooms that cross it are largely bought rather than grown, so the company carries a price exposure to the button mushroom market that a grower does not. It also carries a regulatory load that scales with reach rather than with headcount: 350 people serving more than 80 markets have to satisfy every labelling, additive and food-safety regime along the route, and Asia-Pacific already accounts for 22% of revenue, which ties a Dutch processor to freight rates and to demand in distant regions.

A processor and a grower have to be compared on the right measure. Processing tonnage is intake rather than harvest, so it cannot be read as capacity in the sense used for Snowey or Zongxing, and its utilisation depends on whether raw material is available and affordable in the first place. What it does show is where the money moves: a ranking that measured only growing rooms would treat this model as an absence, when in fact it is the part of the supply chain that converts a perishable crop into a shelf-stable ingredient and prices it accordingly.

Why Are HEPA Rooms, Peat-Free Casing And Recyclable Packaging Now Capacity Requirements Rather Than Sustainability Claims?

Environmental specification has stopped being a claim a supplier makes and become an input a supplier must buy, because retailers and regulators now enforce it through long contracts and hard rules rather than through reputation. HEPA filtration, peat-free casing, recyclable packaging and cleaner energy are capital items whose payback is measured in continued shelf access, and each of them raises the cost of a tonne before it returns anything.

Peat is the clearest case, because a casing layer cannot be swapped without cost. Button mushrooms fruit on a casing soil traditionally built from peat, and European and British rules on peatland protection have turned that material into a liability. BioFungi has moved to a casing that contains no peat at all and grows under EU Organic rules at three plants with HEPA air filtration, which is part of why its cost per tonne sits above the average for this group. Monaghan became the first supplier in the United Kingdom to grow supermarket mushrooms on a fully peat-free system, and that switch was an industrial project rather than a packaging decision, because casing chemistry decides how the crop fruits and how much of it can be sold at all.

Air handling and packaging follow the same logic. Three HEPA-filtered plants allow BioFungi to grow organically without synthetic pesticides, and that certification is what lets 95% or more of its revenue come from organic retailers and processors in Central and Western Europe. Monaghan has moved to recyclable paper and bio-based packaging and holds a five-year agreement with Sainsbury's inside the retailer's £5 billion programme of long-term farm contracts. An agreement of that length converts compliance spending into a defensible position, which is exactly why it is signed with suppliers that have already funded the capital.

Automation and energy sit in the same budget line. Picking is the least automatable step in fresh mushroom production and labour costs have been rising in every market on this page. Costa, its capital freed by the 2024 buyout, has installed automated picking arms with 3D vision and solar generation at its Victorian sites, and Hokuto has automated picking in the same direction. Both are bets that a capital cost is cheaper than a wage bill over the life of the installation, and both depend on a company being able to raise or spend that money in the first place.

What this does to an entrant that cannot fund it. BioFungi is the smallest name here at about 25,000 tonnes a year and roughly 400 employees, and it carries the heaviest relative compliance load of the ten: organic certification, HEPA filtration, peat-free casing and three countries to supply. At the other end of the scale, Monterey spent 24 months having its spent mushroom compost certified organic, which converted a disposal cost into a saleable input rather than a marketing sentence. Compliance pays back when it yields a product or a contract; where it yields only a cost, it narrows the field to the companies able to absorb it.

What Does Going Private Mean For Costa, And What Does It Mean For Monaghan, Scelta And BioFungi?

Going private means one thing for Costa and something quite different for Monaghan, Scelta and BioFungi: a buyout removed a reporting obligation from a company that had one, while the others never had accounts to publish in the first place, and neither case says anything by itself about scale. The practical difference is about what an outside reader can verify, which is why the two situations have to be handled separately rather than folded into a single private category.

Costa's buyout replaced public reporting with an investment mandate. The group was taken private in 2024 by a consortium that includes Paine Schwartz Partners and Driscoll's, having previously traded in Australia under the code CGC. Delisting removed the obligation to explain results to a market every quarter, and it also removed the pressure to defend a half-yearly number, which is a real advantage for a business installing automated picking arms and solar generation at its Victorian mushroom sites, where the return arrives over years rather than over quarters. What a reader loses is the audited trail: the mushroom operation supplies more than three quarters of Australia's fresh mushrooms from about 32,000 tonnes, but those figures rest on company statements and trade reporting rather than on a filing.

Monaghan, Scelta and BioFungi were never public, so there is nothing to compare against. Monaghan is a family-controlled private unlimited company with roughly 3,500 employees, compounding its own compost and casing across six countries and publishing no audited group accounts. Scelta employs about 350 people at four processing plants and its revenue of about US$180 million is an estimate. BioFungi employs about 400 people and grows about 25,000 tonnes, with revenue estimated at about US$130 million. In each case the physical facts are firmer than the financial ones: plant counts, tonnage, certification and export reach can be checked against products on shelves, whereas revenue rests on the publisher named beside it.

The listed names give this page its audited anchors, and they are all filed in Tokyo or Shenzhen. Snowey (300511) and Hualv (300970) file with the Shenzhen ChiNext board, Zongxing (002772) with the Shenzhen main board, and Hokuto (1379) and Yukiguni Maitake (1375) with the Tokyo Stock Exchange Prime Market. Those filings carry the harder numbers: Hokuto's operating profit reached JPY 6.628 billion in its 2025 financial year, up 108.4%; Hualv lifted revenue 25.17% to RMB 1.292 billion and doubled net profit to RMB 110 million; Snowey returned to profit in 2025 with net profit of about RMB 29.8 million after a difficult stretch. None of that is available for the private half of the page.

Disclosure changes what can be verified rather than what exists. A supplier with no audited accounts can still own the compost yard, the rooms and the trucks, while a listed supplier can still be squeezed by electricity, substrate or freight, so the split should not be read as a quality signal in either direction. A supplier with no audited accounts can still own the compost yard, the rooms and the trucks, while a listed supplier can still be squeezed by electricity, substrate or freight. This ranking credits no company with the standing of a parent, an owner or a licensing partner, and membership of the Fortune Global 500 is never inferred from revenue: none of the ten is a member. Contract packing and traded goods are excluded as well, so every figure here describes what a company produces rather than what it moves.